Ranbaxy Laboratories Limited
19, Nehru Place
new Delhi
Tel: 91-11-6452666-72
Fax: ++91-11-6002076
Website: http://www.ranbaxy.com/
Email: seemaa@ranbaxy.co.in
219 articles about Ranbaxy Laboratories Limited
-
Pfizer Inc. Release: Court In The Netherlands Upholds Basic Lipitor Patent, Prevents Launch Of Ranbaxy Laboratories Product Before November 2011
9/13/2006
-
Ranbaxy Laboratories Wins On Two Additional Atorvastatin Patents In Norway
8/29/2006
-
The Day In Review: Celera Diagnostics Buys Another Generic Drug Company
8/21/2006
-
Ranbaxy Laboratories Buys Russian Generic Drugs Maker Akrikhin For $110 Million
8/21/2006
-
Ranbaxy Laboratories Invalidates Pfizer Inc.'s '995 Lipitor U.S. Patent
8/3/2006
-
Ranbaxy Laboratories Subsidiary Ohm Laboratories, Inc. Receives Prestigious 'Private Label Supplier Of The Year Award' From AmerisourceBergen
8/1/2006
-
Ranbaxy Laboratories's Joint Venture In Japan Launches Generic Clarithromycin & Terbinafine Tablets
7/17/2006
-
Ranbaxy Laboratories Release: U.K. Appeals Court Affirms Mixed High Court Of Justice's Ruling In Lipitor(R)* Case
6/28/2006
-
British Appellate Court Rules In Pfizer Inc.'s Favor In Challenge To Basic Lipitor Patent
6/28/2006
-
Ranbaxy Laboratories Announces Strategic Partnership With Zenotech Laboratories For Oncology Products
6/7/2006
-
Ranbaxy Laboratories Successfully Invalidates Atorvastatin Patent In Austria
4/25/2006
-
Ranbaxy Laboratories Acquires Ethimed In Belgium
3/29/2006
-
The Day In Review: Novartis Corporation Inlicenses Idenix Pharmaceuticals, Inc. Drug For $525 Million
3/28/2006
-
Ranbaxy Laboratories Acquires Leading Romanian Pharma Company Terapia For US $324 Million
3/28/2006
-
Takeda Pharmaceutical Co. Ltd. Wins Patent Infringement Case On ACTOS In US
2/24/2006
-
Finland Court Enjoins Ranbaxy Laboratories From Marketing Generic Lipitor
2/22/2006
-
Ranbaxy Laboratories Net Hit By Price Pressure, Gets New CEO
1/18/2006
-
Ranbaxy Laboratories Announces An Agreement With Cephalon, Inc. Regarding Settlement Of PROVIGIL(R) Patent Litigation
12/22/2005
-
Ranbaxy Laboratories To Appeal U.S. District Court Decision Upholding Pfizer Inc. Atorvastatin Patents
12/19/2005
-
Pfizer Inc. Rallies On Favorable Lipitor Ruling
12/19/2005